141
Views
58
CrossRef citations to date
0
Altmetric
Research Article

Mannosylated Niosomes as Adjuvant-Carrier System for Oral Mucosal Immunization

&
Pages 331-345 | Received 21 Oct 2005, Accepted 03 Aug 2006, Published online: 09 Dec 2008

References

  • Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y. J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol 2000; 18: 767–811
  • Constant S. L., Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: The alternative approaches. Annu. Rev. Immunol 1997; 15: 297–322
  • Copland M. J., Baird M. A., Rades T., McKenzie J. L., Becker B., Reck F., Tyler P. C., Davies N. M. Liposomal delivery of antigen to human dendritic cells. Vaccine 2003; 21: 883–890
  • Dima V. F., Ionescu M. D., Palade R., Balotescu C., Becheanu G., Dima S. V. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine. Roum. Arch. Microbiol. Immunol 2001; 60(1)27–54
  • Duzgunes N. Preparation and quantification of small unilamellar and large unilamellar reverse-phase evaporation liposomes. Methods Enzymol 2003; 367: 23–27
  • Elson C. O., Ealding W., Lefkowitz J. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J. Immunol. Methods 1984; 67: 101–108
  • Fabani M. M., Gargini R., Taira M. C., Iacono R., Alonso-Romanowski S. Study of in vitro stability of liposomes and in vivo antibody response to antigen associated with liposomes containing GM1 after oral and subcutaneous immunization. J. Liposome Res 2002; 12(1–2)13–27
  • Fry D. W., White J. C., Goldman I. D. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal. Biochem 1978; 90: 809–815
  • Garcon N., Gregoriadis G., Taylor M., Summerfield J. Mannose-mediated targeted immunoadjuvant action of liposomes. Immunology 1988; 64: 743–754
  • Gregoriadis G. Immunological adjuvants: A role for liposomes. Immunol. Today 1990; 11: 89–97
  • Gutierro I., Hernandez R. M., Igartua M., Gascon A. R., Pedraz J. L. Influence of dose and immunization route on the serum IgG antibody response to TT loaded PLGA microspheres. Vaccine 2002; 20: 2181–2190
  • Halliwell B., Gutteridge J. M. C. Free Radicals in Biology and Medicine. Oxford University Press, Oxford 1989; 50–65
  • Hassan Y., Brewer J. M., Alexander J., Jennings R. Immune responses in mice induced by HSV-1 glycoproteins presented with ISCOMs or NISV delivery systems. Vaccine 1996; 4: 1581–1589
  • Huang W., Bai Y., Wang J. D., Wu J. B., Li G. F., Zhang W. M., Zhou D. Y. Preparation oral liposome-encapsulated recombinant Helicobacter pylori heat shock protein 60 vaccine for prevention of Hp infection. Di Yi Jun Yi Da Xue Xue Bao 2005; 25(5)531–534
  • Irie T., Watarai S., Iwasaki T., Kodama H. Protection against experimental Aeromonas salmonicida infection in carp by oral immunisation with bacterial antigen entrapped liposomes. Fish Shellfish Immunol 2005; 18(3)235–242
  • Irie T., Watarai S., Kodama H. Humoral immune response of carp (Cyprinus carpio) induced by oral immunization with liposome-entrapped antigen. Dev. Comp. Immunol 2003; 27(5)413–421
  • Jackson S., Mestecky J., Childers N. K., Michalek S. M. Liposomes containing anti-idiotypic antibodies: An oral vaccine to induce protective secretory immune response specific for pathogens of mucosal surfaces. Infect. Immun 1990; 58(6)1932–1936
  • Jain S., Singh P., Mishra V., Vyas S. P. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol. Lett 2005; 101(1)41–49
  • Jain S., Vyas S. P. Mannosylated niosomes as carrier adjuvant system for topical immunization. J. Pharm. Pharmacol 2005; 57(9)1177–1184
  • Katz D. E., Delorimier A. J., Wolf M. K., Hall E. R., Cassels F. J., van Hamont J. E., Newcomer R. L., Davachi M. A., Taylor D. N., McQueen C. E. Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) C56 antigen. Vaccine 2003; 21: 341–346
  • Kelsall B. L., Strober W. The role of dendritic cells in antigen processing in the Peyer's patch. Ann. NY Acad. Sci 1996a; 778: 47–54
  • Kelsall B. L., Strober W. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J. Exp. Med 1996b; 183: 237–247
  • Kiwada H., Fujisaki Y., Yamada S., Kato Y. Application of synthetic alkyl glycoside vesicles as drug carriers. I. Preparation and physical properties. Chem. Pharm. Bull 1985; 33: 753–759
  • Lubeck M. D., Steplewski Z., Baglia F., Klein M. H., Dorrington K. J., Koprowski H. The interaction of murine IgG subclass proteins human monocyte Fc receptors. J. Immunol 1985; 135: 1299–1304
  • McGhee J. R., Mestecky J., Dertzbaugh M., Eldridge J. H., Hirasawa M., Kiyono H. The mucosal immune system: From fundamental concepts to vaccine development. Vaccine 1992; 10: 75–88
  • McGhee J. R., Mestecky J., Elson C. D., Kiyono H. Regulation of IgA synthesis and immune response by T cells and interleukins. J. Clin. Immunol 1989; 9: 175–199
  • Medina E., Guzman C. A. Modulation of immune responses following antigen administration by mucosal route. FEMS Immunol. Med. Microbiol 2000; 27: 305–311
  • Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol 1987; 7: 265–276
  • Michalek S. M., Childers N. K., Katz J., Dertzbaugh M., Zhang S., Russell M. W., Macrina F. L., Jackson S., Mestecky J. Liposomes and conjugate vaccines for antigen delivery and induction of mucosal immune responses. Adv. Exp. Med. Biol 1992; 327: 191–198
  • Morokata T., Ishikawa J., Yamada T. Antigen dose defines T helper 1 and T helper 2 responses in the lungs of C57BL/6 and Balb/c mice independently of spleenic responses. Immunol. Lett 2000; 72: 119–126
  • New R. R. C. Introduction and preparation of liposomes. Liposomes: A Practical Approach, R. R. C. New. Oxford University Press, Oxford 1990; 1–104
  • Noguchi Y., Noguchi T., Sato T., Yokoo Y., Itoh S., Yoshida M., Yoshiki T., Akiyoshi K., Sunamoto J., Nakayama E., Shiku H. Priming for in vitro and in vivo anti-human T lymphotropic virus type 1 cellular immunity by virus-related protein reconstituted into liposome. J. Immunol 1991; 146(10)3599–3603
  • Palomino E. Carbohydrate handles as natural resources in drug delivery. Adv. Drug Deliv. Rev 1994; 13: 311–323
  • Perrie Y., Obrenovic M., McCarthy D., Gregoriadis G. Liposome (Lipodine)-mediated DNA vaccination by the oral route. J. Liposome Res 2002; 12(1–2)185–197
  • Rademacher T. W., Parekh R. B., Dwek R. A. Glycobiology. Annu. Rev. Biochem 1988; 57: 785–838
  • Rentel C. O., Bouwstra J. A., Naisbett B., Junginger H. E. Niosomes as a novel peroral vaccine delivery system. Int. J. Pharm 1999; 186(2)161–167
  • Singh P., Prabakaran D., Jain S., Mishra V., Jaganathan K. S., Vyas S. P. Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. Int. J. Pharm 2004; 278: 379–390
  • Sugimoto M., Ohishi K., Fukasawa M., Shikata K., Kawai H., Itakura H., Hatanaka M., Sakakibara R., Ishiguro M., Nakata M., Mizuochi T. Oligomannose-coated liposomes as an adjuvant for the induction of cell-mediated immunity. FEBS Lett 1995; 363(1–2)53–56
  • Sunamoto J., Gato M., Lida T., Hara K., Saito A., Tomonega A. Polymer coated liposomes for drug delivery to target specific organs. Receptor Mediated Targeting of Drugs, G. Gregoriadis, J. Senior, A. Trout. Plenum Press, New York 1985; 359–371
  • Szoka F., Jr., Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. USA 1978; 75: 4194–4198
  • Tana, Watarai S., Isogai E., Oguma K. Induction of intestinal IgA and IgG antibodies preventing adhesion of verotoxin-producing Escherichia coli to Caco-2 cells by oral immunization with liposomes. Lett. Appl. Microbiol 2003; 36(3)135–139
  • Uchegbu I. F., Vyas S. P. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int. J. Pharm 1998; 172: 33–70
  • Venkatesan N., Vyas S. P. Polysaccharide coated liposomes for oral immunization—Development and characterization. Int. J. Pharm 2000; 203: 169–177
  • Vyas S. P., Katare Y. K., Mishra V., Sihorkar V. Ligand directed macrophage targeting of amphotericin B loaded liposomes. Int. J. Pharm 2000; 210: 1–14
  • Yeh M. K., Liu Y. T., Chen J. L., Chiang C. H. Oral immunogenicity of the inactivated Vibrio cholerae whole cell vaccine encapsulated in biodegradable microparticles. J. Control. Rel 2002; 82: 237–247
  • Yoshioka T., Stenberg B., Florence A. T. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (span 20, 40, 60, and 80) and a sorbitan triester (span 85). Int. J. Pharm 1994; 105: 1–6
  • Zho F., Neutra M. R. Antigen delivery to mucosa-associated lymphoid tissues using liposomes as a carrier. Biosci. Rep 2002; 22(2)355–369

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.